Ignite Creation Date:
2024-05-05 @ 4:41 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00293410
Status:
COMPLETED
Last Update Posted:
2010-05-06
First Post:
2006-02-16
Brief Title:
Clofarabine and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Leukemia Chronic Myelogenous Leukemia or Myeloproliferative Disorders
Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization Data
Organization:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Class:
OTHER
Study ID:
J0561 CDR0000456431
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |